Logo
x

Search category

Subscribe Now

label Expansion Application

Novo Nordisk Resubmits Label Expansion Application to the US FDA for Semaglutide (2.0mg)

Novo Nordisk Resubmits Label Expansion Application to the US FDA for Semaglutide (2.0mg)

  • May 31, 2021
Novo Nordisk Report Submission of label Expansion Application to US FDA's for Ozempic (semaglutide) for T2D

Novo Nordisk Report Submission of label Expansion Application to US FDA's for Ozempic (semaglutide) for T2D

  • January 21, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.